Biotech | March 16, 2024
Evonik Vland Biotech JV commences operations
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
The investment will catalyse various components of the IndiaAI Mission
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Acquisition of exclusive commercialization rights for European markets
Subscribe To Our Newsletter & Stay Updated
